Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Enzolytics Inc (ENZC)

Enzolytics Inc (ENZC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ENZC with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0014 +28.57%
on 06/28/24
0.0032 -43.75%
on 06/18/24
-0.0009 (-33.33%)
since 06/05/24
3-Month
0.0014 +28.57%
on 06/28/24
0.0090 -80.00%
on 04/11/24
-0.0069 (-79.31%)
since 04/05/24
52-Week
0.0014 +28.57%
on 06/28/24
0.0603 -97.01%
on 09/18/23
-0.0441 (-96.08%)
since 07/05/23

Most Recent Stories

More News
Enzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox Virus

COLLEGE STATION, TX / ACCESSWIRE / June 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (ENZC" or the "Company") today announced it has identified conserved, immutable sites (epitopes) on the Monkeypox virus....

ENZC : 0.0018 (-10.00%)
CORRECTION: Enzolytics, Inc. Reports Progress and Future Plans

This version includes the Safe Harbor statement that was missing from the previous version of this release. COLLEGE STATION, TX / ACCESSWIRE / April 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/)....

ENZC : 0.0018 (-10.00%)
Enzolytics, Inc. Reports Progress and Future Plans

COLLEGE STATION, TX / ACCESSWIRE / April 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Enzolytics continues to make significant progress in its multiple therapeutic platforms and...

ENZC : 0.0018 (-10.00%)
Enzolytics IPF Immune(TM) Introduced to Large and Small Retail Buyers at Recent ECRM "Weight Management, Nutrition, and Vitamin Program"

COLLEGE STATION, TX / ACCESSWIRE / April 11, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). Large and small retail buyers were introduced to Enzolytics IPF Immuneâ„¢, an immune modulator...

ENZC : 0.0018 (-10.00%)
Enzolytics Highlights Its Comprehensive PCT Patent Applications Covering Discovered Conserved Target Epitopes on the SARS-CoV-2 and HIV Viruses

COLLEGE STATION, TX / ACCESSWIRE / March 25, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/.) In submissions under the Patent Cooperation Treaty (PCT), Enzolytics, Inc. has pending international...

ENZC : 0.0018 (-10.00%)
Enzolytics, Inc. Highlights the Introduction of IPF Immune(TM) as CRN Data Shows Record-Breaking Number of Americans Use Dietary Supplements

COLLEGE STATION, TX / ACCESSWIRE / March 23, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/). 80 Percent of Americans Now Use Nutritional Supplements; Interest in Immunity Protection...

ENZC : 0.0018 (-10.00%)
Enzolytics, Inc.'s Wholly Owned Subsidiary Virogentics, Inc. Reports Progress on the Delivery of its ITV-1 Anti-HIV Therapeutic for Use by Patients in African Regions

COLLEGE STATION, TX / ACCESSWIRE / March 14, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) Enzolytics' ("ENZC") wholly-owned subsidiary Virogentics, Inc. (the "Subsidiary") today announced...

ENZC : 0.0018 (-10.00%)
Enzolytics IPF Immune(TM), an Immune Modulator, Is Introduced into the U.S. Market This Month

COLLEGE STATION, TX / ACCESSWIRE / March 10, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces that Enzolytics IPF Immuneâ„¢, its immune modulator, will be introduced into the...

ENZC : 0.0018 (-10.00%)
Enzolytics, Inc. Announces New Advisory Board Member

COLLEGE STATION, TX / ACCESSWIRE / February 28, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces the addition of Dr. Suraj Kumar Saggar to its Advisory Board. Dr. Saggar brings...

ENZC : 0.0018 (-10.00%)
Enzolytics Announces Its New Technology For Entry Into The In-Vitro Diagnostics Market

COLLEGE STATION, TX / ACCESSWIRE / February 21, 2022 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/) announces its plans for entry into the diagnostics market. Enzolytics has filed a comprehensive...

ENZC : 0.0018 (-10.00%)

Key Turning Points

3rd Resistance Point 0.0021
2nd Resistance Point 0.0020
1st Resistance Point 0.0019
Last Price 0.0018
1st Support Level 0.0017
2nd Support Level 0.0016
3rd Support Level 0.0015

See More

52-Week High 0.0603
Fibonacci 61.8% 0.0378
Fibonacci 50% 0.0309
Fibonacci 38.2% 0.0239
Last Price 0.0018
52-Week Low 0.0014

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar